Cited by 296Pain Mechanisms and TreatmentsAdenosine and Purinergic SignalingNeuroinflammation and Neurodegeneration Mechanisms

P2X7-Dependent Release of Interleukin-1β and Nociception in the Spinal Cord following Lipopolysaccharide

Open access
Clark, Anna K., Staniland, Amelia A., Marchand, Fabien, Kaan, Timothy K. Y., McMahon, Stephen B., Malcangio, Marzia·2010·The Journal of Neuroscience

Abstract

The cytokine interleukin-1β (IL-1β) released by spinal microglia in enhanced response states contributes significantly to neuronal mechanisms of chronic pain. Here we examine the involvement of the purinergic P2X7 receptor in the release of IL-1β following activation of Toll-like receptor-4 (TLR4) in the dorsal horn, which is associated with nociceptive behavior and microglial activation. We observed that lipopolysaccharide (LPS)-induced release of IL-1β was prevented by pharmacological inhibition of the P2X7 receptor with A-438079, and was absent in spinal cord slices taken from P2X7 knock-out mice. Application of ATP did not evoke release of IL-1β from the dorsal horn unless preceded by an LPS priming stimulus, and this release was dependent on P2X7 receptor activation. Extensive phosphorylation of p38 MAPK in microglial cells in the dorsal horn was found to correlate with IL-1β secretion following both LPS and ATP. In behavioral studies, intrathecal injection of LPS in the lumbar spinal cord produced mechanical hyperalgesia in rat hindpaws, which was attenuated by concomitant injections of either a nonspecific (oxidized ATP) or a specific (A-438079) P2X7 antagonist. In addition, LPS-induced hypersensitivity was observed in wild-type but not P2X7 knock-out mice. These data suggest a critical role for the P2X7 receptor in the enhanced nociceptive transmission associated with microglial activation and secretion of IL-1β in the dorsal horn. We suggest that CNS-penetrant P2X7 receptor antagonists, by targeting microglia in pain-enhanced response states, may be beneficial for the treatment of persistent pain.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.3295-09.2010

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Clark, A. K., Staniland, A. A., Marchand, F., Kaan, T. K. Y., McMahon, S. B., & Malcangio, M.
Affiliations
King's College London (GB)
Venue
The Journal of Neuroscience
Published
2010-01-13
Volume
30
Issue
2
Pages
573-582
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2046299505
Cited by
291
References
62
Citations by year
2026: 7 · 2025: 8 · 2024: 14 · 2023: 11 · 2022: 13 · 2021: 17 · 2020: 18 · 2019: 9 · 2018: 9 · 2017: 18 · 2016: 21 · 2015: 28 · 2014: 22 · 2013: 25 · 2012: 26
FWCI
20.79
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Research Portal (King's College London) (submittedVersion)
Funders
  • GlaxoSmithKline
  • Wellcome Trust (081553, 83259)
  • Versus Arthritis
Topics
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
P2X7 receptor, IL-1β, lipopolysaccharide, nociception, spinal microglia, TLR4, dorsal horn, mechanical hyperalgesia, p38 MAPK, purinergic signaling, ATP, chronic pain
MeSH terms
Adenosine Triphosphate, Analysis of Variance, Animals, Dose-Response Relationship, Drug, Enzyme-Linked Immunosorbent Assay, Female, Gene Expression Regulation, Glial Fibrillary Acidic Protein, Hyperalgesia, Lipopolysaccharides, Male, Pain Measurement, Phosphopyruvate Hydratase, Pyridines, Spinal Cord, Tetrazoles, Theophylline, Time Factors, Rats, Wistar, Pain Threshold, Microglia, Receptors, Purinergic P2, Mice, Knockout, Mitogen-Activated Protein Kinase 13, Mice, Rats, Interleukin-1beta, Receptors, Purinergic P2X7, Purinergic P2 Receptor Agonists, Purinergic P2 Receptor Antagonists, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review